S-Space

Browse

Title

전체 가 나 다 라 마 바 사 아 자 차 카 타 파 하

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Sort by
In order
Results/Page
Authors/record

Showing results 4,461 to 4,480 of 7,883

Issue Date	Title / Author(s) / Citation	File
2012	PCR 증폭조건의 변화에 따른 증폭효능의 변화- Two-step PCR 증폭조건을 중심으로 - 김홍현	link
2016-03	PD-L1 expression is associated with epithelial-mesenchymal transition in head and neck squamous cell carcinoma Ock, Chan-Young; Kim, Sehui; Keam, Bhumsuk; Kim, Miso; Kim, Tae Min; Kim, Jin-Ho; Jeon, Yoon Kyung; Lee, Ju-Seog; Kwon, Seong Keun; Hah, J. Hun; Kwon, Tack-Kyun; Kim, Dong-Wan; Wu, Hong-Gyun; Sung, Myung-Whun; Heo, Dae Seog Oncotarget, Vol.7 No.13, pp.15901-15914	view file DOI
2017-11	PD-L1 immunohistochemical assays for assessment of therapeutic strategies involving immune checkpoint inhibitors in non-small cell lung cancer: a comparative study Kim, Hyojin; Kwon, Hyun Jung; Park, Soo Young; Park, Eunhyang; Chung, Jin-Haeng Oncotarget, Vol.8 No.58, pp.98524-98532	DOI
2022-03	Pearls and Pitfalls of Oblique Lateral Interbody Fusion: A Comprehensive Narrative Review Kim, Hyoungmin; Chang, Bong-Soon; Chang, Sam Yeol Neurospine, Vol.19 No.1, pp.163-176	DOI
2022-09	Pediatric Cases of Recurrent Skull Giant Osteoma Misdiagnosed as Fibrous Dysplasia Kim, Yumin; Kim, Byungjun Journal of Craniofacial Surgery, Vol.33 No.6, pp.e562-e564	DOI
2022-05	Pediatric Spine Trauma An, Sungjae; Hyun, Seung-Jae Journal of Korean Neurosurgical Society, Vol.65 No.3, pp.361-369	DOI
2022-10	Pediatric-Type Indolent B-Cell Lymphomas With Overlapping Clinical, Pathologic, and Genetic Features Lim, Sojung; Lim, Ka Young; Koh, Jiwon; Bae, Jeong Mo; Yun, Hongseok; Lee, Cheol; Kim, Young A.; Paik, Jin Ho; Jeon, Yoon Kyung American Journal of Surgical Pathology, Vol.46 No.10, pp.1397-1406	DOI
2022-08	Pelvic radiography as a non-invasive screening tool for hiatal hernia in children with cerebral palsy Yoo, In Hyuk; Yang, Hye Ran Medicine, Vol.101 No.33, p. e29522	DOI
2020-04	Pembrolizumab After Two or More Lines of Previous Therapy in Patients With Recurrent or Metastatic SCLC: Results From the KEYNOTE-028 and KEYNOTE-158 Studies Chung, Hyun Cheol; Piha-Paul, Sarina A.; Lopez-Martin, Jose; Schellens, Jan H. M.; Kao, Steven; Miller, Wilson H., Jr.; Delord, Jean-Pierre; Gao, Bo; Planchard, David; Gottfried, Maya; Zer, Alona; Jalal, Shadia I.; Penel, Nicolas; Mehnert, Janice M.; Matos, Ignacio; Bennouna, Jaafar; Kim, Dong-Wan; Xu, Lei; Krishnan, Suba; Norwood, Kevin; Ott, Patrick A. Journal of Thoracic Oncology, Vol.15 No.4, pp.618-627	DOI
2019-07	Pembrolizumab alone or in combination with chemotherapy as first-line therapy for patients with advanced gastric or gastroesophageal junction adenocarcinoma: results from the phase II nonrandomized KEYNOTE-059 study Bang, Yung-Jue; Kang, Yoon-Koo; Catenacci, Daniel V.; Muro, Kei; Fuchs, Charles S.; Geva, Ravit; Hara, Hiroki; Golan, Talia; Garrido, Marcelo; Jalal, Shadia I.; Borg, Christophe; Doi, Toshihiko; Yoon, Harry H.; Savage, Mary J.; Wang, Jiangdian; Dalal, Rita P.; Shah, Sukrut; Wainberg, Zev A.; Chung, Hyun Cheol Gastric Cancer, Vol.22 No.4, pp.828-837	DOI
2016-06	Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial Muro, Kei; Chung, Hyun Cheol; Shankaran, Veena; Geva, Ravit; Catenacci, Daniel; Gupta, Shilpa; Eder, Joseph Paul; Golan, Talia; Le, Dung T.; Burtness, Barbara; McRee, Autumn J.; Lin, Chia-Chi; Pathiraja, Kumudu; Lunceford, Jared; Emancipator, Kenneth; Juco, Jonathan; Koshiji, Minori; Bang, Yung-Jue The Lancet Oncology, Vol.17 No.6, pp.717-726	DOI
2018-03	Pembrolizumab in Asia-Pacific patients with advanced head and neck squamous cell carcinoma: Analyses from KEYNOTE-012 Tahara, Makoto; Muro, Kei; Hasegawa, Yasuhisa; Chung, Hyun Cheol; Lin, Chia-Chi; Keam, Bhumsuk; Takahashi, Kenichi; Cheng, Jonathan D.; Bang, Yung-Jue Cancer Science, Vol.109 No.3, pp.771-776	DOI
2017-12	Pembrolizumab in Patients With Extensive-Stage Small-Cell Lung Cancer: Results From the Phase Ib KEYNOTE-028 Study Ott, Patrick A.; Elez, Elena; Hiret, Sandrine; Kim, Dong-Wan; Morosky, Anne; Saraf, Sanatan; Piperdi, Bilal; Mehnert, Janice M. Journal of Clinical Oncology, Vol.35 No.34, pp.3823-3829	DOI
2020-05	Pembrolizumab plus chemotherapy as neoadjuvant treatment of high-risk, early-stage triple-negative breast cancer: results from the phase 1b open-label, multicohort KEYNOTE-173 study Schmid, P.; Salgado, R.; Park, Y. H.; Munoz-Couselo, E.; Kim, S. B.; Sohn, J.; Im, S. -A.; Foukakis, T.; Kuemmel, S.; Dent, R.; Yin, L.; Wang, A.; Tryfonidis, K.; Karantza, V.; Cortes, J.; Loi, S. Annals of Oncology, Vol.31 No.5, pp.569-581	DOI
2023-11	Pembrolizumab Plus Chemotherapy Followed by Pembrolizumab in Patients With Early Triple-Negative Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial Takahashi, Masato; Cortés, Javier; Dent, Rebecca; Pusztai, Lajos; McArthur, Heather; Kümmel, Sherko; Denkert, Carsten; Park, Yeon Hee; Im, Seock-Ah; Ahn, Jin-Hee; Mukai, Hirofumi; Huang, Chiun-Sheng; Chen, Shin-Cheh; Kim, Min Hwan; Jia, Liyi; Li, Xin Tong; Tryfonidis, Konstantinos; Karantza, Vassiliki; Iwata, Hiroji; Schmid, Peter Jama Network Open, Vol.6 No.11, p. e2342107	DOI
2022-07	Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer Cortes, Javier; Rugo, Hope S.; Cescon, David W.; Im, Seock-Ah; Yusof, Mastura M.; Gallardo, Carlos; Lipatov, Oleg; Barrios, Carlos H.; Perez-Garcia, Jose; Iwata, Hiroji; Masuda, Norikazu; Otero, Marco Torregroza; Gokmen, Erhan; Loi, Sherene; Guo, Zifang; Zhou, Xuan; Karantza, Vassiliki; Pan, Wilbur; Schmid, Peter New England Journal of Medicine, Vol.387 No.3, pp.217-226	DOI
2020-12	Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial Cortes, Javier; Cescon, David W.; Rugo, Hope S.; Nowecki, Zbigniew; Im, Seock-Ah; Yusof, Mastura Md; Gallardo, Carlos; Lipatov, Oleg; Barrios, Carlos H.; Holgado, Esther; Iwata, Hiroji; Masuda, Norikazu; Torregroza Otero, Marco; Gokmen, Erhan; Loi, Sherene; Guo, Zifang; Zhao, Jing; Aktan, Gursel; Karantza, Vassiliki; Schmid, Peter The Lancet, Vol.396 No.10265, pp.1817-1828	DOI
2016-04	Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial Herbst, Roy S.; Baas, Paul; Kim, Dong-Wan; Felip, Enriqueta; Perez-Gracia, Jose L.; Han, Ji-Youn; Molina, Julian; Kim, Joo-Hang; Arvis, Catherine Dubos; Ahn, Myung-Ju; Majem, Margarita; Fidler, Mary J.; de Castro, Gilberto, Jr.; Garrido, Marcelo; Lubiniecki, Gregory M.; Shentu, Yue; Im, Ellie; Dolled-Filhart, Marisa; Garon, Edward B. The Lancet, Vol.387 No.10027, pp.1540-1550	DOI
2021-04	Pembrolizumab versus investigator-choice chemotherapy for metastatic triple-negative breast cancer (KEYNOTE-119): a randomised, open-label, phase 3 trial Winer, Eric P.; Lipatov, Oleg; Im, Seock-Ah; Goncalves, Anthony; Munoz-Couselo, Eva; Lee, Keun Seok; Schmid, Peter; Tamura, Kenji; Testa, Laura; Witzel, Isabell; Ohtani, Shoichiro; Turner, Nicholas; Zambelli, Stefania; Harbeck, Nadia; Andre, Fabrice; Dent, Rebecca; Zhou, Xuan; Karantza, Vassiliki; Mejia, Jaime; Cortes, Javier The Lancet Oncology, Vol.22 No.4, pp.499-511	DOI
2022-01	Pembrolizumab versus paclitaxel for previously treated PD-L1-positive advanced gastric or gastroesophageal junction cancer: 2-year update of the randomized phase 3 KEYNOTE-061 trial Fuchs, Charles S.; Ozguroglu, Mustafa; Bang, Yung-Jue; Di Bartolomeo, Maria; Mandala, Mario; Ryu, Min-Hee; Fornaro, Lorenzo; Olesinski, Tomasz; Caglevic, Christian; Chung, Hyun C.; Muro, Kei; Van Cutsem, Eric; Elme, Anneli; Thuss-Patience, Peter; Chau, Ian; Ohtsu, Atsushi; Bhagia, Pooja; Wang, Anran; Shih, Chie-Schin; Shitara, Kohei Gastric Cancer, Vol.25 No.1, pp.197-206	DOI

1 220 221 222 223 224 225 226 395